NFκB enhances metabolic adaptation in cancer (Mauro et al., 2011), and P53 blocks activation of NFκB by inhibiting glycolysis (Kawauchi et al., 2008), P53 induction in these cells is regulated by TIGAR (Sinha et al., 2013). Here, TP53 is linked to cancer.